Skip to main content
Dishman Carbogen Amcis Limited logo

Dishman Carbogen Amcis Limited — Investor Relations & Filings

Ticker · DCAL ISIN · INE385W01011 LEI · 335800KM9GDZE9W21C94 BSE.NS Manufacturing
Open in API
Filings indexed 561 across all filing types
Latest filing 2026-05-25 Call Transcript
Country IN India
Listing BSE.NS DCAL

About Dishman Carbogen Amcis Limited

https://imdcal.com/

Dishman Carbogen Amcis Limited is a global contract development and manufacturing organization providing integrated services for the development and manufacture of active pharmaceutical ingredients. The company specializes in high potency APIs, offering a comprehensive range of services from process research and development to commercial-scale production. Its portfolio includes vitamin D and its analogs, cholesterol, and specialty chemicals. The organization supports drug development cycles with technical expertise in complex chemistry and niche technologies, operating through a network of facilities across multiple continents. Additionally, the company provides disinfectant products and services for various industrial applications, maintaining a focus on technical innovation and quality standards throughout the product lifecycle.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 92% confidence The document is the full text of an earnings conference call transcript, including opening remarks by management, a detailed financial review, and operational discussion for the quarter and year ended March 31, 2026. It is not merely an earnings release summary, but the verbatim transcript of the Q4 FY26 call, fitting the definition of a Call Transcript (CT).
2026-05-25 English
Please find enclosed herewith transcript of Con Call arranged on 20.05.2026.
Call Transcript Classification · 98% confidence The document is an earnings conference call transcript filed under SEBI regulations, containing the full text of the Q4 FY26 and year-end March 31, 2026 earnings call, including participant introductions, management commentary, and financial Q&A. This clearly matches the definition of a Call Transcript (CT).
2026-05-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a notice under SEBI Listing Regulations sent to BSE and NSE, informing the exchanges that the audio recording of the earnings conference call for Q4 FY2025-26 is now available on the company website. It does not contain actual financial data or call transcript text, nor is it a formal financial report. It is a regulatory announcement/filing. Therefore, it falls under the general Regulatory Filings (RNS) category.
2026-05-20 English
The audio recording of Conference call arranged by the Company with investors on Wednesday, 20th May, 2026 which was commenced at 15:00 hrs (IST) to discuss the financial result and performance ....
Report Publication Announcement Classification · 90% confidence The document is a short notice filed under SEBI regulations to the stock exchanges, informing investors that the audio recording of the recent earnings conference call is now available on the company’s website (with a download link). It does not contain any financial results, analysis, or transcript; rather it simply announces the release/publication of the call recording. Under the 'menu vs meal' rule, this is an announcement of a report’s publication, not the report itself. Therefore it should be classified as a Report Publication Announcement (RPA).
2026-05-20 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a multi-page presentation titled “Investor Presentation” containing detailed quarterly and full‐year financial highlights, segment performance, consolidated P&L, balance sheet, business overview, and forward‐looking statements. It is issued under SEBI Regulations 30 and 51 to BSE and NSE and includes actual presentation slides. This fits the definition of an Investor Presentation (code IP).
2026-05-20 English
PFA Investor Presentaion
Investor Presentation Classification · 98% confidence The document is a presentation titled “Investor Presentation on Audited financial result – Q4FY26 & FY26” delivered under SEBI regulations, containing slides with detailed financial highlights, P&L, balance sheet, segment analysis, company overview, and forward-looking statements. This matches the definition of an Investor Presentation (IP).
2026-05-20 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.